Rosalia Emma

- development of artificial intelligence algorithms using next-generation devices and sensors to modify cardiopulmonary risk factors and real-life clinical validation pilot study

- study of diseases related to the use of cigarettes

- clinical and toxicological assessment of the harm of cigarette smoking

- study of the reduction of smoking-related harm

- clinical and toxicological assessment of the use of tobacco alternative devices (e-cigarettes and heated tobacco products)

- molecular phenotyping of allergic asthma, severe asthma and asthma in smokers

Keywords

Tobacco Harm Reduction, Alternative products to cigarette smoke, Tobacco related diseases, Toxicology

- Review Editor for the Frontiers in Physiology Journal (Specialty section: Respiratory Physiology and Pathophysiology) - Impact Factor: 4.755 - dal 03/07/2018 to date.

- Review Editor for the Frontiers in Pharmacology Journal (Specialty section: Experimental Pharmacology and Drug Discovery) - Impact Factor: 5.988 - dal 03/07/2018 to date.